Bufferin Regular Strength Pain Relief

Product NDC
50066-610
11-digit product format
500660610
Labeler code
50066
Product ID
50066-610_4f652a68-82a2-4c22-acc4-2cb28f96b358
Type
HUMAN OTC DRUG
Nonproprietary name
aspirin
Dosage form
TABLET, COATED
Route
ORAL
Labeler
Genomma Lab USA
Application
M013
Marketing category
OTC MONOGRAPH DRUG
Marketing start
2021-05-17
Substance
ASPIRIN
Active strength
325 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Bufferin Regular Strength Pain Relief
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ASPIRIN325 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
UniiR16CO5Y76E
Rxcui212033, 260847

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
e2db08c6-133f-4f4f-afb4-e90a2418d6f6Product name120230320
d7724692-1155-4cc8-a415-22f5fc4aec35Product name620220216
ce6d5c06-3ae0-18a6-d5b3-8cd3cc0f8906Product name720210625
bde672ba-4805-28d0-1986-73543d41b412Product name220210201
f52be47f-7aa7-46c0-b1fa-50c18dd50206Product name120201029
11ed6f83-cdd2-4637-8379-b1a1d3ae3cdeProduct name120181101
86c45a79-b9f0-4476-a27c-6e10db098497Product name120180125
f212291f-05fe-9603-fc7e-bd73e38ce1e6Product name220161129
ade821ba-260a-47e2-bd89-743e27ac9906Product name120161121
182f9ab4-4ab5-c449-200f-87ce2ce8e550Product name220151105
9425d234-4ae1-4b53-adc6-8cc7af6dd657Product name120150929
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
2a21311a-89e2-0e83-2ebd-117f9798b2b2Product name120140508
9007e8a7-ff50-f9b9-7945-f2a1deadd94eProduct name120140508
96c2be53-8e44-452d-56a2-d255b2f1af2dProduct name120140508
bf8bd5f7-495f-4022-2780-7ded7ea7ea44Product name120140508

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50066-610-13Bufferin Regular Strength Pain Relief130 in 1 BOTTLE, PLASTICTABLET, COATED1302
50066-610-13Bufferin Regular Strength Pain Relief1 in 1 CARTONTABLET, COATED12
50066-610-30Bufferin Regular Strength Pain Relief30 in 1 BOTTLE, PLASTICTABLET, COATED302
50066-610-30Bufferin Regular Strength Pain Relief1 in 1 CARTONTABLET, COATED12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50066-610BUFFERIN REGULAR STRENGTH PAIN RELIEF (ASPIRIN) TABLET, COATED [GENOMMA LAB USA]2Current NDC, Legacy NDC, 4 package rows20250227_3543b2bf-1062-468a-a5dc-eabb2408af8c.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
212033aspirin 325 MG Oral TabletPSN3543b2bf-1062-468a-a5dc-eabb2408af8c2
260847Bufferin 325 MG Oral TabletPSN3543b2bf-1062-468a-a5dc-eabb2408af8c2
260847aspirin 325 MG Oral Tablet [Bufferin]SBD3543b2bf-1062-468a-a5dc-eabb2408af8c2
212033aspirin 325 MG Oral TabletSCD3543b2bf-1062-468a-a5dc-eabb2408af8c2
212033ASA 325 MG Oral TabletSY3543b2bf-1062-468a-a5dc-eabb2408af8c2
260847ASA 325 MG Oral Tablet [Bufferin]SY3543b2bf-1062-468a-a5dc-eabb2408af8c2
260847Bufferin 325 MG Oral TabletSY3543b2bf-1062-468a-a5dc-eabb2408af8c2

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
50066-610-13500660610131 BOTTLE, PLASTIC in 1 CARTON (50066-610-13) / 130 TABLET, COATED in 1 BOTTLE, PLASTIC2021-05-170000-00-00NoNoCurrent
50066-610-30500660610301 BOTTLE, PLASTIC in 1 CARTON (50066-610-30) > 30 TABLET, COATED in 1 BOTTLE, PLASTIC2021-05-170000-00-00NoNoCurrent